Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05523960
What this trial is testing

Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery

Who this might be right for
Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 652
Not applicableStudy completedNCT02852525
What this trial is testing

Confocal Laser Probe to Treat Barrett's Esophagus

Who this might be right for
Barrett's Esophagus
Virendra Joshi 29
Not applicableStudy completedNCT05604950
What this trial is testing

Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophagectomyRadiotherapy+1 more
Yongtao Han 2
Testing effectiveness (Phase 2)Study completedNCT03719924
What this trial is testing

Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Federation Francophone de Cancerologie Digestive 106
Early research (Phase 1)Looking for participantsNCT04615013
What this trial is testing

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Who this might be right for
Cervical Esophagus AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8+10 more
M.D. Anderson Cancer Center 24
Large-scale testing (Phase 3)Looking for participantsNCT04821843
What this trial is testing

Neoadjuvant Treatment Modalities in Esophageal Cancer

Who this might be right for
Esophageal CancerChemotherapy EffectChemoradiation+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2,000
Not applicableStudy completedNCT01882478
What this trial is testing

Cryotherapy -BEATS-RF Ablation Trial

Who this might be right for
Barrett's Esophagus With Persistent Dysplasia orEarly Esophageal Adenocarcinoma Post Radio Frequency Ablation
Mayo Clinic 15
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Not applicableStudy completedNCT03455608
What this trial is testing

PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer

Who this might be right for
Dysphagia
University Health Network, Toronto 952
Not applicableLooking for participantsNCT00260585
What this trial is testing

Esophageal Cancer Risk Registry

Who this might be right for
Esophageal CancerGastroesophageal Reflux Disease (GERD)Esophageal Diseases+2 more
University of Pittsburgh 7,000
Large-scale testing (Phase 3)UnknownNCT02604615
What this trial is testing

The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy

Who this might be right for
Stage III Esophageal Squamous Cell CarcinomaEsophageal Neoplasms
The First Affiliated Hospital of Henan University of Science and Technology 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Testing effectiveness (Phase 2)Study completedNCT00815308
What this trial is testing

Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shandong Cancer Hospital and Institute 55
Not applicableNot Yet RecruitingNCT07573397
What this trial is testing

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fudan University 88
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Not applicableNot Yet RecruitingNCT05954117
What this trial is testing

Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia

Who this might be right for
Esophageal Adenocarcinoma
University Hospital, Clermont-Ferrand 60
Testing effectiveness (Phase 2)Ended earlyNCT00004897
What this trial is testing

Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Northwestern University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03641313
What this trial is testing

Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+5 more
National Cancer Institute (NCI) 17
Not applicableEnded earlyNCT01366833
What this trial is testing

Optimal Management of Malignant Dysphagia

Who this might be right for
Malignant DysphagiaEsophageal Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre 3
Next Page